Moon Surgical's Maestro System powered by NVIDIA Holoscan paves the way to next-generation laparoscopy, with over 200 patients treated

19 Mar 2024
PARIS and SAN FRANCISCO, March 19, 2024 /PRNewswire/ --
Moon Surgical's Maestro, with embarked NVIDIA Holoscan, delivers surgeon autonomy in the first commercial use.
Moon Surgical today announced that over 200 patients have been successfully treated with its Maestro System, powered by NVIDIA Holoscan, which delivers surgeon autonomy in its first commercial use in various surgical interventions.
Continue Reading
"Maestro System powered by NVIDIA Holoscan paves the way to next-generation laparoscopy, with over 200 patients treated" - Kimberly Powell, Vice President of Healthcare at NVIDIA
Post this
The Maestro System is used in laparoscopy, where surgeons operate through small incisions with an internal camera and instruments. The System is powered by NVIDIA Holoscan, a powerful edge computing platform that allows real-time algorithms based on Artificial Intelligence (AI) to be deployed in the operating room for immediate benefits during surgery.
In late 2021, Moon Surgical earned a spot in NVIDIA's Inception Program, designed to accelerate startup growth by providing access to advanced technical resources and pioneering technology. One such technology was the NVIDIA Holoscan, NVIDIA's inaugural platform dedicated to medical technology, which the Moon Surgical team provided input on during development. Moon Surgical has now integrated Holoscan into its commercial Maestro System to enable its first computer vision-based capability, the ScoPilot™.
Maestro's ScoPilot provides autonomy for the surgeon, who must normally rely on other staff to control the laparoscope. This task requires continuous coordination and anticipation. Surgeons can use ScoPilot to control the laparoscope themselves without taking their hands off surgical instruments, which are often engaged with other critical surgical tasks. Over ten surgeons have used the Maestro System and ScoPilot across two hospitals in France.
"Surgeons are astounded by the fluidity and speed that ScoPilot introduces to the operating room," remarked Anne Osdoit, CEO of Moon Surgical and Partner at Sofinnova Partners. "This is the perfect illustration that Maestro is ready for more digital features, enabled by NVIDIA Holoscan, that deliver transformative experiences for the operating room."
"AI is at the top of mind for the next wave of MedTech innovators like Moon Surgical, who seek to deliver innovative solutions to surgeons, nurses, and patients," stated Kimberly Powell, Vice President of Healthcare at NVIDIA. "This proof-of-concept showing an AI application running on NVIDIA Holoscan in real-time during Maestro surgery validates the principle behind our platform."
Moon Surgical, based in Paris, France, and San Francisco, California, is building the OR of the future, one that is digitalized, efficient, and sustainable. The combined power of the transformative Maestro System and the intelligent Maestro OS empowers healthcare teams to make confident decisions and provide better surgical care for their patients. Founded in 2020, Moon Surgical prides itself on staying nimble, prioritizing innovation, and building a culture of inclusivity, creativity, and collaboration among its multi-cultural team members.
Moon Surgical. Inspiring and Innovating the Art of Surgery.
Check us out at www.moonsurgical.com or follow us on LinkedIn.
SOURCE Moon Surgical
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
-
Targets
-
Drugs
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.